UBS Group’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

UBS Group’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,333	Closed	-$1K	–	10688
2021 Q2	$1K	Sell	1,333 -4,101	-75%	-$2.94K	﹤0.01%	9323
2021 Q1	$5K	Buy	+5,434	New	+$6.01K	﹤0.01%	8380

UBS Group's CHAQ.WS Position: Q3 2021 in Review

UBS Group sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 1,333 shares — an estimated $1K sold.

UBS Group first reported a position in CHAQ.WS in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

UBS Group reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
UBS Group sold 1,333 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $1K.
UBS Group first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q1 2021 and held it in 2 quarters.
UBS Group's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $5K in Q1 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.